DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the GALAXY MEDICARE LIMITED (GML) share price today?

GALAXY MEDICARE LIMITED (GML) is trading at ₹17.55 on the NSE, down 1.68% on the day. Source: DocStoX.

What is the PE ratio of GALAXY MEDICARE LIMITED?

GALAXY MEDICARE LIMITED has a price-to-earnings (PE) ratio of 6.2 in the Healthcare sector.

What is the market capitalisation of GALAXY MEDICARE LIMITED?

GALAXY MEDICARE LIMITED has a market capitalisation of approximately ₹27 crore.

GALAXY MEDICARE LIMITED

GML·NSE·Healthcare

₹17.55▼ -0.30 (-1.68%)

Healthcare · Medical Equipment

A steady, established business

52W₹15

₹546%

Open

₹17.55

High

₹17.55

Low

₹17.55

Prev Close

₹17.85

Volume

2.0K

VWAP

₹17.55

Snapshot

Key fundamentals

Market Cap

₹27 Cr

P/E Ratio

6.18Cheap

P/B Ratio

0.79

EPS

₹2.84

Book Value

₹22.77

ROE

10.60%Average

ROCE

17.72%Decent

Dividend Yield

1.94%

Debt / Equity

0.10Low

Face Value

₹10.00

52W High

₹54.00

52W Low

₹15.15

Sector

Healthcare

Industry

Medical Equipment

Strong Buy

Narrow moatMedium uncertainty

Fair value estimate

₹27

▲ 53.6%upside

Trading at ₹18 — 54% below our estimate

BearFair valueBull

₹23₹27₹34

/100

Business quality — Solid

Growth 68Profitability 33Efficiency 24Valuation 98

Plain English

Our view

A steady, established business
Low debt relative to equity
Fundamental red flags (Piotroski 1/9)

Strengths

Low debt relative to equity
Profit growing 30% a year
Reasonably priced at 6× earnings
Promoters hold a controlling stake

Risks

Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

14% ROE fading to 12% over ~10 yrs, on ₹23 book

₹25

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹34

Analyst target

No analyst coverage

—

Blended fair value₹27

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Profit growing 30% a year
Reasonably priced at 6× earnings
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

6.2Cheap

Below 15× is value territory; above 35× prices in strong growth

ROE

10.6%Average

Above 15% is considered healthy for Indian equities

ROCE

17.7%Decent

Above 18% means capital is working hard

Debt/Eq

0.10Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹27 Cr

P/B

0.79

EPS

₹2.84

Div Yield

1.94%

What changed

Recent changes

Domestic institutions-1.9% stake last quarter
Promoters+0.55% stake last quarter

What matters

News impact

Overview

Valuation

Attractive

P/E 6.2×

Growth

Steady

+9% rev CAGR

Profitability

Modest

10.6% ROE

Financial health

Rock solid

D/E 0.10

Momentum

N/A

No technicals

Today

Trading activity

Delivery %100.0%

Turnover₹35,100 Cr

Trades1

VWAP₹17.55

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+8.9%

—

10Y

—

Profit

+31.9%

—

10Y

—

EPS

-24.2%

—

10Y

—

Profile

Pros

Stock is trading at 0.71 times its book value

Watch-outs

Cons

The company has delivered a poor sales growth of 6.96% over past five years.
Company has a low return on equity of 13.5% over last 3 years.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 0.55 pts; domestic institutions reduced 1.85 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

73%

Promoter

Promoters

73.0%+0.55

Public

27.0%+1.29

FII / FPI

0.0%0.00

DII

0.0%-1.85

Total shareholders

867+850 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter72.98%

Public27.02%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in July 1992, Galaxy Medicare Limited manufactures and exports medical devices, POP bandages, and surgical dressings in India.[1]